SCI时时刷

search
+
Author Correction: Antimalarial drug discovery: progress and approaches
Authors and AffiliationsUniversity of California, San Diego, La Jolla, CA, USAJair L. Siqueira-Neto & Elizabeth A. Win...
Creating an AI-first drug discovery engine
Creating an AI-first drug discovery engine
Najat Khan — Chief R&D Officer and Chief Commercial Officer at Recursion — discusses the proposed merger of Recursion ...
Targeting cytokine networks in neuroinflammatory diseases
Targeting cytokine networks in neuroinflammatory diseases
In neuroinflammatory diseases, systemic (blood-borne) leukocytes invade the central nervous system (CNS) and lead to tissu...
Neurons give metastatic cells a push
Discover the world’s best science and medicine | Nature.com
Splice-switching ASO curtails brain calcification
Discover the world’s best science and medicine | Nature.com
PPAR agonists provide new treatment options for inflammatory liver disease
PPAR agonists provide new treatment options for inflammatory liver disease
Discover the world’s best science and medicine | Nature.com
RIPTACs expand anticancer target space
RIPTACs expand anticancer target space
Discover the world’s best science and medicine | Nature.com
Upcoming market catalysts in Q4 2024
Upcoming market catalysts in Q4 2024
Discover the world’s best science and medicine | Nature.com
Understanding anellovirus immune evasion
Discover the world’s best science and medicine | Nature.com
Apolipoprotein L2 inhibitor mitigates fibrosis
Discover the world’s best science and medicine | Nature.com
Targeting the peripheral neural-tumour microenvironment for cancer therapy
Targeting the peripheral neural-tumour microenvironment for cancer therapy
As the field of cancer neuroscience expands, the strategic targeting of interactions between neurons, cancer cells and oth...
Protein isoform-centric therapeutics: expanding targets and increasing specificity
Protein isoform-centric therapeutics: expanding targets and increasing specificity
Most protein-coding genes produce multiple protein isoforms; however, these isoforms are commonly neglected in drug discov...
Degrading cell-free DNA to prevent recurrent stroke
Degrading cell-free DNA to prevent recurrent stroke
Discover the world’s best science and medicine | Nature.com
Engineered parasite delivers proteins to the brain
Discover the world’s best science and medicine | Nature.com
The breast cancer drug market
The breast cancer drug market
Discover the world’s best science and medicine | Nature.com
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
Over the past 40 years, the muscarinic acetylcholine receptor family, particularly the M1-receptor and M4-receptor subtype...
FDA approves IDH1 and IDH2 inhibitor for brain cancer
Discover the world’s best science and medicine | Nature.com
FDA approves first TCR-engineered T cell therapy, for rare soft-tissue cancer
Discover the world’s best science and medicine | Nature.com
Per-patient approach to calculating drug development costs yields lower estimate
Discover the world’s best science and medicine | Nature.com
Comprehensive measurement of biopharmaceutical R&D investment
Comprehensive measurement of biopharmaceutical R&D investment
Discover the world’s best science and medicine | Nature.com
Epigenetic editor silences prion protein
Discover the world’s best science and medicine | Nature.com
Oral miniproteins treat IBD
Discover the world’s best science and medicine | Nature.com
Opioid antidote gets a boost
Opioid antidote gets a boost
Discover the world’s best science and medicine | Nature.com
TCR-boosted T cell therapy yields proof-of-principle clinical data in solid cancer
TCR-boosted T cell therapy yields proof-of-principle clinical data in solid cancer
Discover the world’s best science and medicine | Nature.com
Muscarinic drugs breathe new life into schizophrenia pipeline
Muscarinic drugs breathe new life into schizophrenia pipeline
Karuna and Bristol Myers Squibb’s muscarinic agonist KarXT looks set to offer the first new drug mechanism for patients wi...
Chinese innovative drug R&D trends in 2024
Chinese innovative drug R&D trends in 2024
Discover the world’s best science and medicine | Nature.com
Anti-IL-11 antibody shows anti-ageing properties
Anti-IL-11 antibody shows anti-ageing properties
Discover the world’s best science and medicine | Nature.com
Proteogenomics identifies anticancer targets
Discover the world’s best science and medicine | Nature.com
Author Correction: Sequential immunotherapy: towards cures for autoimmunity
In the version of the article initially published, the following text was missing from the Acknowledgements, and has now b...
Antibody sniffs out tau
Discover the world’s best science and medicine | Nature.com
阅读更多
format_indent_increase